Cancer Research UK logo.
SearchDonate
  • Search

A study to see whether circulating tumour cells can affect how well treatment for neuroendocrine tumours works (CALM-NET)

Overview

Cancer types:

Neuroendocrine tumour (NET)

Status:

Results

Phase:

Other

Details

This study was for people with a neuroendocrine tumour in their bowel. It was done to see if having circulating tumour cells can affect how well treatment is likely to work.

The study was open for people to join between 2014 and 2016. The team published the results in 2022.

Recruitment start: 16 May 2014

Recruitment end: 22 July 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Meyer

Supported by

Experimental Cancer Medicine Centre (ECMC)

Ipsen

NIHR Clinical Research Network: Cancer

Last reviewed: 21 Nov 2022

CRUK internal database number: 11851

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.